Matches in SemOpenAlex for { <https://semopenalex.org/work/W4287463600> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W4287463600 abstract "Sodium-glucose cotransporter 2 inhibitor (SGLT2i) has been reported to improve glycemic control. This study was designed to investigate the effects of SGLT2i dapagliflozin (dapa) on cardiomyopathy induced by isoproterenol (ISO) and its potential mechanisms. Fifty male Sprague Dawley rats were randomly assigned to the control (n=10) and the ISO (2.5 mg/kg/day)-treated groups (n=40). After 2 weeks, the 28 surviving rats with obvious left ventricular dysfunction in the ISO group were randomized into three medication groups, including the angiotensin receptor neprilysin inhibitor (ARNI) sacubitril/valsartan group (S/V, n=9), the dapa group (n=9), and the ISO group (n=10) for 4 weeks. Next, electrical programmed stimulation was performed in all the groups to evaluate their susceptibility to ventricular arrhythmias (VAs). Compared to the ISO rats, the dapa administration not only effectively reduced the cumulative risk of death, the myocardial fibrosis, the plasma angiotensin II levels and its functional receptor AT1R protein expressions in the heart, and the proinflammatory cytokine levels in the cardiac tissue of the ISO-treated rats, but it also improved their cardiac function and inhibited oxidative stress. These effects were similar to S/V. However, dapa showed a greater efficacy than S/V in reducing the left ventricular end-diastolic volumes, lowing the heart rates and VAs, and decreasing the body weights and plasma glucose levels. The mechanisms by which dapa exerts protective effects on cardiomyopathy may be related to its indirect antioxidant capacity and direct hypoglycemic action." @default.
- W4287463600 created "2022-07-25" @default.
- W4287463600 creator A5000057073 @default.
- W4287463600 creator A5007222967 @default.
- W4287463600 creator A5015789973 @default.
- W4287463600 creator A5021369812 @default.
- W4287463600 creator A5022526821 @default.
- W4287463600 creator A5031529603 @default.
- W4287463600 creator A5046946757 @default.
- W4287463600 creator A5065208984 @default.
- W4287463600 creator A5081635779 @default.
- W4287463600 date "2021-01-01" @default.
- W4287463600 modified "2023-10-18" @default.
- W4287463600 title "The cardioprotective effect of the sodium-glucose cotransporter 2 inhibitor dapagliflozin in rats with isoproterenol-induced cardiomyopathy." @default.
- W4287463600 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34650776" @default.
- W4287463600 hasPublicationYear "2021" @default.
- W4287463600 type Work @default.
- W4287463600 citedByCount "6" @default.
- W4287463600 countsByYear W42874636002022 @default.
- W4287463600 countsByYear W42874636002023 @default.
- W4287463600 crossrefType "journal-article" @default.
- W4287463600 hasAuthorship W4287463600A5000057073 @default.
- W4287463600 hasAuthorship W4287463600A5007222967 @default.
- W4287463600 hasAuthorship W4287463600A5015789973 @default.
- W4287463600 hasAuthorship W4287463600A5021369812 @default.
- W4287463600 hasAuthorship W4287463600A5022526821 @default.
- W4287463600 hasAuthorship W4287463600A5031529603 @default.
- W4287463600 hasAuthorship W4287463600A5046946757 @default.
- W4287463600 hasAuthorship W4287463600A5065208984 @default.
- W4287463600 hasAuthorship W4287463600A5081635779 @default.
- W4287463600 hasConcept C126322002 @default.
- W4287463600 hasConcept C134018914 @default.
- W4287463600 hasConcept C164027704 @default.
- W4287463600 hasConcept C2776151105 @default.
- W4287463600 hasConcept C2776553924 @default.
- W4287463600 hasConcept C2776914184 @default.
- W4287463600 hasConcept C2777180221 @default.
- W4287463600 hasConcept C2777387769 @default.
- W4287463600 hasConcept C2777422806 @default.
- W4287463600 hasConcept C2778198053 @default.
- W4287463600 hasConcept C2778797674 @default.
- W4287463600 hasConcept C2779676291 @default.
- W4287463600 hasConcept C500558357 @default.
- W4287463600 hasConcept C555293320 @default.
- W4287463600 hasConcept C71924100 @default.
- W4287463600 hasConcept C78085059 @default.
- W4287463600 hasConcept C84393581 @default.
- W4287463600 hasConcept C98274493 @default.
- W4287463600 hasConceptScore W4287463600C126322002 @default.
- W4287463600 hasConceptScore W4287463600C134018914 @default.
- W4287463600 hasConceptScore W4287463600C164027704 @default.
- W4287463600 hasConceptScore W4287463600C2776151105 @default.
- W4287463600 hasConceptScore W4287463600C2776553924 @default.
- W4287463600 hasConceptScore W4287463600C2776914184 @default.
- W4287463600 hasConceptScore W4287463600C2777180221 @default.
- W4287463600 hasConceptScore W4287463600C2777387769 @default.
- W4287463600 hasConceptScore W4287463600C2777422806 @default.
- W4287463600 hasConceptScore W4287463600C2778198053 @default.
- W4287463600 hasConceptScore W4287463600C2778797674 @default.
- W4287463600 hasConceptScore W4287463600C2779676291 @default.
- W4287463600 hasConceptScore W4287463600C500558357 @default.
- W4287463600 hasConceptScore W4287463600C555293320 @default.
- W4287463600 hasConceptScore W4287463600C71924100 @default.
- W4287463600 hasConceptScore W4287463600C78085059 @default.
- W4287463600 hasConceptScore W4287463600C84393581 @default.
- W4287463600 hasConceptScore W4287463600C98274493 @default.
- W4287463600 hasLocation W42874636001 @default.
- W4287463600 hasOpenAccess W4287463600 @default.
- W4287463600 hasPrimaryLocation W42874636001 @default.
- W4287463600 hasRelatedWork W1372849 @default.
- W4287463600 hasRelatedWork W13767151 @default.
- W4287463600 hasRelatedWork W14519780 @default.
- W4287463600 hasRelatedWork W17607225 @default.
- W4287463600 hasRelatedWork W20379510 @default.
- W4287463600 hasRelatedWork W21121384 @default.
- W4287463600 hasRelatedWork W6628010 @default.
- W4287463600 hasRelatedWork W6856088 @default.
- W4287463600 hasRelatedWork W13680394 @default.
- W4287463600 hasRelatedWork W3386323 @default.
- W4287463600 isParatext "false" @default.
- W4287463600 isRetracted "false" @default.
- W4287463600 workType "article" @default.